Self-Assessment: Toxic Myopathies & Neuropathies | Advances in Duchenne Treatment & Management

From 2023 Annual Meeting session content.

Course Description

This self-assessment course is created from two sessions held at the 2023 Annual Meeting.

Toxic Myopathies and Neuropathies
Identify iatrogenic and noniatrogenic causes of muscle and nerve toxicity; articulate the mechanisms underlying muscle and nerve toxicity; diagnose and classify various forms of toxic myopathies and neuropathies based on their clinical presentation, EDX findings, and histopathologic characteristics; and manage toxic myopathies and neuropathies.

Advances in Duchenne Treatment and Management
Describe the new and emerging drug therapies and treatment approaches in the management of Duchenne muscular dystrophy. Discuss the relative roles of each of these and how they are changing the approach to care for these patients.

Objectives:
1.Identify both iatrogenic (treatment-induced) and noniatrogenic (non-treatment-related) causes of muscle and nerve toxicity, recognizing the key factors that contribute to these conditions.
2. Describe and discuss the new and emerging drug therapies and treatment approaches available for the management of Duchenne muscular dystrophy, staying current with the latest developments in the field.

To claim self-assessment (SA) credit, you must watch the session recordings and answer a post-test. You must get above a 70% on the post-test survey to claim credit.

The American Board of Psychiatry and Neurology (ABPN) and the American Board of Physical Medicine and Rehabilitation (ABPMR) have reviewed and approved this product as part of a comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification (MOC).

ACCREDITATION STATEMENT : The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION :
The AANEM designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit expires 11/1/2026.

Summary


Availability:	On-Demand
	Expires on Nov 01, 2026


Cost:	Member: $50.00 Non-Member: $75.00


Credit Offered:	3 SA CME Credits 3 CEU Credits